These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25012136)

  • 1. Haploinsufficiency of the insulin-like growth factor-1 receptor enhances endothelial repair and favorably modifies angiogenic progenitor cell phenotype.
    Yuldasheva NY; Rashid ST; Haywood NJ; Cordell P; Mughal R; Viswambharan H; Imrie H; Sukumar P; Cubbon RM; Aziz A; Gage M; Mbonye KA; Smith J; Galloway S; Skromna A; Scott DJ; Kearney MT; Wheatcroft SB
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2051-8. PubMed ID: 25012136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration.
    Kahn MB; Yuldasheva NY; Cubbon RM; Smith J; Rashid ST; Viswambharan H; Imrie H; Abbas A; Rajwani A; Aziz A; Baliga V; Sukumar P; Gage M; Kearney MT; Wheatcroft SB
    Diabetes; 2011 Apr; 60(4):1295-303. PubMed ID: 21317296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice.
    Imrie H; Viswambharan H; Sukumar P; Abbas A; Cubbon RM; Yuldasheva N; Gage M; Smith J; Galloway S; Skromna A; Rashid ST; Futers TS; Xuan S; Gatenby VK; Grant PJ; Channon KM; Beech DJ; Wheatcroft SB; Kearney MT
    Diabetes; 2012 Sep; 61(9):2359-68. PubMed ID: 22733797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells.
    Suh W; Kim KL; Choi JH; Lee YS; Lee JY; Kim JM; Jang HS; Shin IS; Lee JS; Byun J; Jeon ES; Kim DK
    Biochem Biophys Res Commun; 2004 Aug; 321(1):65-71. PubMed ID: 15358216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation.
    Cho YL; Hur SM; Kim JY; Kim JH; Lee DK; Choe J; Won MH; Ha KS; Jeoung D; Han S; Ryoo S; Lee H; Min JK; Kwon YG; Kim DH; Kim YM
    J Biol Chem; 2015 Jan; 290(1):467-77. PubMed ID: 25391655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.
    Wegiel B; Gallo DJ; Raman KG; Karlsson JM; Ozanich B; Chin BY; Tzeng E; Ahmad S; Ahmed A; Baty CJ; Otterbein LE
    Circulation; 2010 Feb; 121(4):537-48. PubMed ID: 20083679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.
    Abbas A; Imrie H; Viswambharan H; Sukumar P; Rajwani A; Cubbon RM; Gage M; Smith J; Galloway S; Yuldeshava N; Kahn M; Xuan S; Grant PJ; Channon KM; Beech DJ; Wheatcroft SB; Kearney MT
    Diabetes; 2011 Aug; 60(8):2169-78. PubMed ID: 21677284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.
    Ii M; Takeshita K; Ibusuki K; Luedemann C; Wecker A; Eaton E; Thorne T; Asahara T; Liao JK; Losordo DW
    Circulation; 2010 Mar; 121(9):1104-12. PubMed ID: 20176991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice.
    Li FY; Lam KS; Tse HF; Chen C; Wang Y; Vanhoutte PM; Xu A
    Circulation; 2012 Sep; 126(10):1267-77. PubMed ID: 22851545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
    Guo J; Breen DM; Pereira TJ; Dalvi PS; Zhang H; Mori Y; Ghanim H; Tumiati L; Fantus IG; Bendeck MP; Dandona P; Rao V; Dolinsky VW; Heximer SP; Giacca A
    Atherosclerosis; 2015 Jul; 241(1):111-20. PubMed ID: 25974101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury.
    Li M; Yu J; Li Y; Li D; Yan D; Ruan Q
    Cell Reprogram; 2010 Aug; 12(4):405-15. PubMed ID: 20698779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW
    Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis.
    Yamaguchi Y; Kuwana M
    Histol Histopathol; 2013 Feb; 28(2):175-83. PubMed ID: 23275301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.
    Sachdev D; Hartell JS; Lee AV; Zhang X; Yee D
    J Biol Chem; 2004 Feb; 279(6):5017-24. PubMed ID: 14615489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition.
    Werner N; Priller J; Laufs U; Endres M; Böhm M; Dirnagl U; Nickenig G
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1567-72. PubMed ID: 12377731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinlike Growth Factor-Binding Protein-1 Improves Vascular Endothelial Repair in Male Mice in the Setting of Insulin Resistance.
    Aziz A; Haywood NJ; Cordell PA; Smith J; Yuldasheva NY; Sengupta A; Ali N; Mercer BN; Mughal RS; Riches K; Cubbon RM; Porter KE; Kearney MT; Wheatcroft SB
    Endocrinology; 2018 Feb; 159(2):696-709. PubMed ID: 29186427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.